Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5545_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •1: Structure of Matter
- •2: Radioactive Decay
- •2.1 Spontaneous Fission
- •1.1.1 Radiation
- •1.2 The Atom
- •1.2.3 Nuclear Binding Energy
- •1.3 Nuclear Nomenclature
- •1.5 Questions
- •Suggested Readings
- •2.2 Isomeric Transition
- •2.2.1 Gamma (γ)-Ray Emission
- •2.2.2 Internal Conversion
- •2.2.2.1 Problem 2.1
- •2.2.2.2 Answer
- •2.3 Alpha (α)-Decay
- •2.4 Beta (β−)-Decay
- •2.5 Positron (β+)-Decay
- •2.6 Electron Capture
- •2.7 Questions
- •Suggested Readings
- •3.1 Radioactive Decay Equation
- •3.1.1 General Equation
- •3.1.2 Half-Life
- •3.1.3 Mean Life
- •3.1.4 Effective Half-Life
- •3.2 Units of Radioactivity
- •3.3 Specific Activity
- •3.4 Calculation
- •3.5 Successive Decay Equations
- •3.5.1 General Equation
- •3.5.2 Transient Equilibrium
- •3.5.3 Secular Equilibrium
- •3.6 Questions
- •Suggested Readings
- •4.5 Poisson Distribution
- •4.6 Gaussian Distribution
- •4.7 Chi-Square Test
- •4.8 Minimum Detectable Activity
- •4.10 Questions
- •Suggested Readings
- •5.1 Cyclotron-Produced Radionuclides
- •5.2 Reactor-Produced Radionuclides
- •5.2.1 Fission or (n, f) Reaction
- •5.2.2 Neutron Capture or (n, γ) Reaction
- •5.6 Radionuclide Generators
- •5.8 Questions
- •Suggested Readings
- •6.1.1 Specific Ionization
- •6.1.2 Linear Energy Transfer
- •6.1.3 Range
- •6.1.4 Bremsstrahlung
- •6.1.5 Positron Annihilation
- •6.2.1.1 Photoelectric Effect
- •6.2.1.2 Compton Scattering
- •6.2.1.3 Pair Production
- •6.2.1.4 Raleigh Scattering
- •6.2.1.5 Photodisintegration
- •6.3.2 Half-Value Layer
- •6.5 Questions
- •Suggested Readings
- •7: Gas-Filled Detector
- •7.1 Principles of Gas-Filled Detector
- •7.2 Ionization Chamber
- •7.2.1 Ion Chamber Survey Meter
- •7.2.2 Dose Calibrator
- •7.2.2.1 Constancy
- •7.2.2.2 Accuracy
- •7.2.2.3 Linearity
- •7.2.2.4 Geometry
- •7.2.3 Pocket Dosimeter
- •7.3 Proportional Counter
- •7.4 Geiger–Müller Counter
- •7.5 Questions
- •Suggested Readings
- •8.1 Scintillation Counter
- •8.4.3 Characteristic X-Ray Peak
- •8.4.4 Backscatter Peak
- •8.4.5 Iodine Escape Peak
- •8.2 Solid Scintillation Detector
- •8.2.1 NaI (Tl) Detector
- •8.2.2 Bismuth Germanate Detector
- •8.2.3 Barium Fluoride Detector
- •8.2.4 Lutetium Oxyorthosilicate Detector
- •8.2.5 Gadolinium Oxyorthosilicate Detector
- •8.2.6 Yttrium Oxyorthosilicate Detector
- •8.2.7 Yttrium Aluminum Perovskite Detector
- •8.2.8 Lutetium Yttrium Oxyorthosilicate Detector
- •8.2.9 Lanthanum Bromide Detector
- •8.3 Solid-State Detector
- •8.3.2 Cadmium–Zinc–Tellurium Detector
- •8.3.3 Cesium Iodide (CsI(Tl)) Detector
- •8.3.4 Solid Scintillation Counter
- •8.3.4.1 NaI(Tl) Detector
- •8.3.4.2 Photomultiplier Tube
- •8.3.4.3 Preamplifier
- •8.3.4.4 Linear Amplifier
- •8.3.4.5 Pulse-Height Analyzer
- •8.3.4.6 Display or Storage
- •8.4 Gamma-Ray Spectrometry
- •8.4.1 Photopeak
- •8.4.6 Positron Annihilation Peak
- •8.4.7 Coincidence Peak
- •8.5 Liquid Scintillation Counter
- •8.5.1 Quenching
- •8.6.1 Energy Resolution
- •8.6.2 Detection Efficiency
- •8.6.2.1 Intrinsic Efficiency
- •8.6.2.2 Photopeak Efficiency or Photofraction
- •8.6.2.3 Geometric Efficiency
- •8.6.3 Dead Time
- •8.7 Gamma Well Counter
- •8.8 Thyroid Probe
- •8.8.1 Thyroid Uptake Measurement
- •8.9 Questions
- •Suggested Readings
- •9: Gamma Camera
- •9.1 Gamma Camera
- •9.1.2 Detector
- •9.1.3 Collimator
- •9.1.4 Photomultiplier Tube
- •9.1.5 X-, Y-Positioning Circuit
- •9.1.6 Pulse-Height Analyzer
- •9.2 Digital Camera
- •9.2.1 Solid State Digital Camera
- •9.3 Questions
- •Suggested Readings
- •10.1.1 Spatial Resolution
- •10.1.1.1 Intrinsic Resolution
- •10.1.1.2 Collimator Resolution
- •10.1.1.3 Scatter Resolution
- •10.1.2.1 Bar Phantom
- •10.1.2.2 Line-Spread Function
- •10.1.2.3 Modulation Transfer Function
- •10.1.3 Sensitivity
- •10.1.3.1 Collimator Efficiency
- •10.1.4 Uniformity
- •10.1.5 Pulse-Height Variation
- •10.1.6 Nonlinearity
- •10.1.7 Edge Packing
- •10.2 Gamma Camera Tuning
- •10.4 Contrast
- •10.4.1 Count Density
- •10.4.2 Image Noise
- •10.4.4 High Count Rate
- •10.4.6 Patient Motion
- •10.5.1 Daily Checks
- •10.5.1.2 Uniformity
- •10.5.2 Weekly Checks
- •10.5.3 Monthly Checks
- •10.5.3.1 High-Count Uniformity Calibration
- •10.5.3.2 Collimator Integrity
- •10.5.4 Annual, Semiannual, or As-Needed Checks
- •10.6 Questions
- •References and Suggested Readings
- •11.1.1 Central Processing Unit
- •11.1.2 Computer Memory
- •11.1.3 External Storage Device
- •11.1.4 Input/Output Device
- •11.1.7 Digital-to-Analog Conversion
- •11.1.8 Digital Image
- •11.2.1 Digital Data Acquisition
- •11.2.2 Static Study
- •11.2.3 Dynamic Study
- •11.2.4 Gated Study
- •11.2.7 Display
- •11.3.1 PACS
- •11.4 Questions
- •Suggested Readings
- •12: Single Photon Emission Computed Tomography
- •12.1 Tomographic Imaging
- •12.2 Single Photon Emission Computed Tomography
- •12.2.1 Data Acquisition
- •12.2.2 Image Reconstruction
- •12.2.2.1 Simple Backprojection
- •12.2.2.2 Filtered Backprojection
- •12.2.2.3 The Convolution Method
- •12.2.2.4 The Fourier Method
- •12.2.2.6 Iterative Reconstruction
- •12.3 SPECT/CT Scanner
- •12.4 Factors Affecting SPECT
- •12.4.1 Photon Attenuation
- •12.4.2 Attenuation Correction Methods
- •12.5 Partial-Volume Effect
- •12.5.2 Sampling
- •12.5.3 Scattering
- •12.6.1 Spatial Resolution
- •12.6.2 Sensitivity
- •12.6.3 Other Parameters
- •12.7.1 Daily Tests
- •12.7.2 Weekly Tests
- •12.7.2.1 Spatial Resolution
- •12.9 Questions
- •References and Suggested Readings
- •13: Positron Emission Tomography
- •13.1 Introduction
- •13.2 PET Radiopharmaceuticals
- •13.3.2 Block Detector
- •13.5 Coincidence Timing Window
- •13.6 PET/CT Scanner
- •13.7 PET/MR Scanner
- •13.7.2 MR Scanner
- •13.7.3 Commercial PET/MR Scanner
- •13.8 Mobile PET or PET/CT Scanner
- •13.9 Micro-PET Scanner
- •13.11 Data Acquisition
- •13.12 Image Reconstruction
- •13.13 Factors Affecting PET
- •13.13.1 Normalization
- •13.13.2 Photon Attenuation Correction
- •13.13.4 Random Coincidences
- •13.13.5 Scatter Coincidences
- •13.13.6 Dead Time
- •13.13.7 Radial Elongation
- •13.14.1 Spatial Resolution
- •13.14.2 Sensitivity
- •13.14.2.1 Noise Equivalent Count Rate
- •13.15.1 Daily Tests
- •13.15.1.1 Sinogram Check
- •13.15.2 Weekly Tests
- •13.15.2.1 Normalization
- •13.18 Questions
- •References and Suggested Reading
- •14.1 Background
- •14.5 Artificial Neural Network
- •14.7 Machine Learning
- •14.7.1 Decision Tree
- •14.7.2 Random Forest
- •14.7.3 Support Vector Machine
- •14.7.4 Computer Vision
- •14.8 Deep Learning
- •14.8.1 Convolutional Network
- •14.8.2 Recurrent Neural Network
- •14.8.3 Generative Adversarial Network
- •14.8.4 Transfer Learning
- •14.9 Radiomics
- •14.10 Natural Language Processing
- •14.11 Large Language Model
- •14.12 Generative Artificial Intelligence
- •14.13.1 Prompt
- •14.13.2 Token
- •14.13.3 Hallucination
- •14.13.4 Deepfake
- •14.13.5 Overfitting
- •14.15 Chatbot
- •14.18 Legal Implication
- •14.20 Questions
- •References
- •15.1 Introduction
- •15.2.1 Scheduling
- •15.2.2 Image Acquisition
- •15.2.3 Image Processing
- •15.2.4 Interpretation
- •15.2.5 Reporting
- •15.3.1 Oncology
- •15.3.2 Cardiovascular Disease
- •15.3.3 Bone Scintigraphy
- •15.3.4 Thyroid Imaging
- •15.5 Drug Development
- •15.6 Questions
- •References and Suggested Reading
- •16: Internal Radiation Dosimetry
- •16.1 Radiation Unit
- •16.1.1 Roentgen
- •16.1.2 Rad
- •16.1.3 Gray
- •16.1.4 Rem
- •16.1.5 Radiation Weighting Factor
- •16.1.6 Quality Factor
- •16.1.7 Sievert
- •16.2 Dose Calculation
- •16.2.1 Radiation Dose Rate
- •16.2.2 Cumulative Radiation Dose
- •16.2.3 Factors Affecting Ã
- •16.2.4 The S Values
- •16.4 Pediatric Dosage
- •16.5 Questions
- •References and Suggested Readings
- •17: Radiation Biology
- •17.1 The Cell
- •17.2.1 DNA Molecule
- •17.2.2 Chromosome
- •17.5 Cell Survival Curves
- •17.6 Factors Affecting Radiosensitivity
- •17.6.1 Dose Rate
- •17.6.2 Linear Energy Transfer
- •17.6.4 Chemicals
- •17.7 Radiosensitizer
- •17.7.1 Oxygen
- •17.7.2 Pyrimidine
- •17.7.3 Others
- •17.8 Radioprotector
- •17.9 Apoptosis
- •17.13.1 Hematopoietic Syndrome
- •17.13.2 Gastrointestinal Syndrome
- •17.13.3 Cerebrovascular Syndrome
- •17.14.1 Somatic Effects
- •17.14.1.1 Carcinogenesis
- •17.14.1.3 Dose–Response Relationship
- •17.14.1.5 Leukemia
- •17.14.1.6 Breast Cancer
- •17.14.1.7 Other Cancers
- •17.14.1.10 Nonspecific Life-Shortening
- •17.14.1.11 Cataractogenesis
- •17.14.2 Genetic Effects
- •17.14.2.1 Spontaneous Mutation
- •17.14.2.2 Doubling Dose
- •17.14.2.3 Genetically Significant Dose
- •17.17 Questions
- •References and Suggested Readings
- •18.1 Introduction
- •18.2 Radiation Protection
- •18.2.3 Occupational Dose Limits
- •18.2.4 ALARA Program
- •18.2.5.1 Time
- •18.2.5.2 Distance
- •18.2.5.3 Shielding
- •18.2.5.4 Activity
- •18.2.6 Personnel Monitoring
- •18.2.6.1 Film Badge
- •18.2.6.2 Thermoluminescent Dosimeter
- •18.2.6.3 Optically Stimulated Luminescence Dosimeter
- •18.3 Radiation Regulations
- •18.3.1 License
- •18.3.1.1 General License
- •18.3.1.2 Specific License of Limited Scope
- •18.3.1.3 Specific Licenses of Broad Scope
- •18.3.2 Radiation Safety Committee
- •18.3.3 Radiation Safety Officer
- •18.3.4.3 Supervision
- •18.3.4.4 Mobile Nuclear Medicine Service
- •18.3.4.5 Written Directives
- •18.4 Bioassay
- •18.6 Radioactive Waste Disposal
- •18.6.2 Release into Sewerage Systems
- •18.6.4 Other Disposal Methods
- •18.7 Radioactive Spill
- •18.8 Recordkeeping
- •18.10 Dirty Bombs
- •18.11 Types of Accidental Radiation Exposure
- •18.12 Protective Measures in Case of Explosion of a Dirty Bomb
- •18.13 Verification Card for Radioactive Patients
- •18.14 Radiation Phobia
- •18.15 European Regulations Governing Radiation
- •18.16 Questions
- •References and Suggested Readings
- •Index

328
10
01200
Dose (Rad or cGy)
Se
DD
2
1.0
0.1
0.01
17 Radiation Biology
n
D
q
D
o
High LET
D
o
Low LET
0.001
200 4000 600 800100
Fig. 17.11 Typical cell survival curves. The cell survival curve for low linear energy transfer
(LET) radiations shows a shoulder of width D
, which is called the quasithreshold dose. After Dq,
q
the plot becomes linear on a semilog scale, indicating an exponential dose–response relationship.
The extrapolation number n is obtained by extrapolating the linear portion of the curve back to the
ordinate. D
is the dose obtained from the slope of the linear portion of the curve, at which 37% of
0
the cells survive. The survival curve for high-LET radiations shows no or little shoulder, indicating
D
to be zero and n to be unity
q
Although Eq. (17.1) has some merit in expressing cell killing by radiation, the
linear-quadratic model provides a more accurate description of the radiationinduced cell killing. This model is mathematically expressed as
(17.2)
where S is the survival fraction of the cells irradiated with dose D, and α and β are
constants. For low-LET radiations, βD2 is negligible at low doses, and the cell survival is proportional to the dose only, making the survival curve linear (Fig.17.12).
At higher doses, the cell survival is proportional to the square of the dose, and the
curve tends to bend, becoming concave downward (Fig.17.12). For high-LET radiations, β is zero, and so the survival curve becomes linear.

10
2200
Dose (Rad or cGy)
17.6 Factors Aecting Radiosensitivity
329
Fig. 17.12 Cell survival
curves based on linearquadratic model. The
initial slope of the
linear-logarithmic plot
gives cell killing
proportional to e
latter part to e
−βD2
−αD
and the
which
bends at higher doses. With
high-LET radiations, β is
zero, and the curve is
exponentially expressed
simply by e
−αD
1.0
0.1
0.01
0.001
e-αD
2
e-βD
Low LET
High LET
4000 800 1600
1200
17.6 Factors Affecting Radiosensitivity
As already mentioned, various factors affect the radiation damage in the cell and
hence the survival curve. The dose rate, the LET of the radiation, the presence of
chemical molecules, and the stage of the cell cycle all affect the survival curve.
17.6.1 Dose Rate
The dose rate, that is, the delivery of dose per unit time, is an important factor in
cellular damage. The higher the rate of dose delivery, the greater will be the cell
damage. At low-dose rates, only single-strand breaks of DNA molecules occur, and
so cells have time to repair, whereas at high-dose rates double-strand breaks occur,
and so repair is less likely to occur because of the shorter time available to the cells
between ionizing events. Figure17.13 illustrates the effects of two dose rates on the
cell survival curve. The dose-rate effect is very important in radiation therapy,
because unless an appropriate dose rate is prescribed, intended therapeutic effect
may not be achieved. When a total dose is given to a patient in fractions over a
period of time, it should be kept in mind that the interval between fractional doses
should be short enough to keep repair of damage to abnormal cells to a minimum.
17.6.2 Linear Energy Transfer
High-LET radiations (e.g., α-particles, neutrons) do not exhibit a dose-rate effect on
the survival curve. Also at high-dose rates (above 100rad/min) of low- and moderateLET radiations, no dose-rate effects are observed on the survival curve in contrast
to low-dose rates. Thus, high-LET radiations exhibit no shoulder (i.e., no Dq) on the

330
10
DOSE (Rad or cGy)
Fig. 17.13 The cell
survival curves indicating
the effect of dose rates. At
high dose rates, the
shoulder of the curve is
reduced, with smaller
values of D
is true at low dose rates
. The opposite
q
17 Radiation Biology
1.0
0.1
High Dose Rate
0.01
0.001
600 1200 1600400
Low Dose Rate
survival curve resulting in an extrapolation number of 1 (Fig.17.12). High-LET
radiations are densely ionizing radiations causing more double-strand breaks in the
DNA molecules, and thus leading to more cell deaths than low-LET radiations,
which are sparsely ionizing radiations (e.g., x-rays, γ-rays). Radiation damage by
high-LET radiations is so severe that the chances of repair are minimal, and even if
repair takes place, the cell is likely to be defective.
17.6.3 Stage ofCell Cycle
Radiation damage mostly occurs during the period of mitosis, the M phase, whereas
least damage occurs during the DNA synthesis, the S phase. Thus, the stage of the
cell cycle determines the extent of radiation damage. If mitotic death occurs in a cell
after irradiation, the irradiated cell may go through one, two, or more mitotic phases
trying to divide, but ultimately dies. Exposure of cells to 100–1000 rad (100–1000
cGy) causes a delay in the G2 phase to M phase transition. An exposure of 1000 rad
(1000 cGy) inhibits the progression of the S phase cells by 30%, whereas the S
phase to G2 phase transition is not affected by such an exposure (Prasad 1995).

17.7 Radiosensitizer
331
17.6.4 Chemicals
Several chemicals, if present during irradiation, have been found to augment or
diminish the effects of radiation on cells. Agents that enhance the cell response to
radiation are called radiosensitizers, and those that protect cells from radiationinduced damage are called radioprotectors.
17.7 Radiosensitizer
17.7.1 Oxygen
Oxygen is the best-known sensitizer encountered in radiation biology. It has been
found that hypoxic cells are resistant to radiation, whereas oxygenated cells are
highly radiosensitive. Such radiosensitization by oxygen is called the oxygen effect
and is measured by a quantity called the oxygen enhancement ratio (OER). The
OER is given by the ratio of the dose required to produce a given radiation damage
to cells in the absence of oxygen to that required to produce the same damage in the
presence of oxygen. The oxygen effect occurs only when oxygen is administered
simultaneously with radiation. It increases with O2 tension up to 30mm Hg, and
remains constant at higher O2 tension. For mammalian cells, the oxygen concentration required to produce a radiation response midway between hypoxic and aerobic
conditions is approximately 0.5%. The OER value reaches a maximum of 3.0 for
x- and γ-radiations, whereas it is about unity for high-LET radiations such as
α-particles.
Figure 17.14 illustrates the effects of oxygen on the survival curve. The presence
of oxygen makes the curve much steeper, indicating the augmentation of cellular
damage at smaller doses relative to the situation of no oxygen. The mechanism of
the oxygen effect is not clearly understood, but is most likely related to DNA strand
breaks. It has been postulated, however, that oxygen combines with already formed
free radicals, R•, to produce the peroxidyl group RO
the DNA molecules. While normally R• could recombine with complementary
molecular components to repair the cell, RO
•
is an altered chemical entity and can-
2
not help in cell repair. The oxygen effect is most predominant for γ- and x-rays, and
is practically absent for high-LET radiations (e.g., α-particles).
It is known that hypoxic cells are present in tumors to varying extents and exhibit
resistance to radiation or chemical therapy of tumors. Tumor hypoxia is caused by
an imbalance between the O2 supply and its consumption in the cell that results from
inadequate blood supply due to structural change, difculty in blood diffusion, or
therapy-induced anemia. Hypoxia, in addition to reducing therapeutic efcacy,
enhances malignant progression. The mean oxygen tension (pO2) in hypoxic tumor
cells is substantially lower than in normal cells (~2mm Hg for solid tumors versus
~50mm Hg for normal tissues). To achieve greater efcacy in radiation treatment
of tumors, it has been advocated to oxygenate the tumor cells and then to apply
radiation to oxygenated cells. Oxygenation of patients has been carried out by
•
, which is more damaging to
2

332
Fig. 17.14 The cell
survival curve illustrating
the effect of oxygen. In the
presence of oxygen, the
curve becomes steeper,
indicating effective killing
of the cells by radiation
17 Radiation Biology
having the patient breathe in a chamber lled with oxygen at 2–3 times the atmospheric pressure. Another method involves the administration of carbogen (a mixture of 95% oxygen and 5% CO
) alone or in combination with nicotinamide.
2
Treatment of oxygenated cells with radiation has resulted in only limited success. It
has been found experimentally that the proportion of hypoxic cells in a tumor
remains the same before and after fractionated radiation therapy. Logically, radiotherapy should have killed more oxygenated cells and thus raised the proportion of
hypoxic cells. Instead, it remains the same and has brought in the argument of reoxygenation of the tumor cells during fractional radiation therapy, provided sufcient
time is allowed for this to happen. This phenomenon has an important implication
in radiation therapy in that even though the proportion of hypoxic cells remains the
same, the total number of hypoxic tumor cells will be killed by radiation over time,
thus leading to a successful treatment. The degree of reoxygenation varies with
tumor types. The mechanism of reoxygenation has been attributed to the fact that as
the tumor shrinks in size, surviving cells that were previously deprived of oxygen
diffusion due to distal location of the blood vessels nd themselves closer to the
blood supply and so reoxygenate.

17.8 Radioprotector
333
17.7.2 Pyrimidine
Halogenated pyrimidines such as 5-chlorodeoxyuridine (ClUDR),
5- bromodeoxyuridine (BUDR), and 5-iododeoxyuridine (IUDR) are useful radiosensitizers. When cells are treated with these drugs for several days before irradiation with x- or γ-rays, cells become highly sensitive to radiation. Potentiation of
radiosensitivity is due to the fact that these drugs are similar to the DNA precursor
thymidine, and therefore are incorporated into the DNA molecule, making them
more susceptible to damage by radiation. For optimal therapeutic gain in radiotherapy, patients should be treated for a period of time extending over several cell
cycles to maximize drug incorporation into the cells.
17.7.3 Others
Radiosensitizers such as actinomycin D, puromycin, methotrexate, and 5- uorouracil
have been successfully used in combination with radiation to treat cancer. Whether
these agents truly increase radiosensitivity or are simply toxic to the cells is still
not clear.
Investigators have been trying to explore radiosensitizing chemicals to substitute
for oxygen which requires the use of a high-pressure technique. Metronidazole
(Flagyl), having a structure with high electron afnity, is a good radiosensitizer for
hypoxic cells. Another useful radiosensitizer for hypoxic cells is misonidazole,
which also has high electron afnity. Misonidazole is almost ten times more effective than metronidazole in sensitizing hypoxic cells. However, clinical trials with
this agent provided only disappointing results. Another radiosensitizer of this kind
is etanidazole, which is less toxic than misonidazole, and has great potential in
radiotherapy. Most side effects of these products are related to neurotoxicity. These
compounds are described as “oxygen mimics”.
17.8 Radioprotector
The most common radioprotectors—substances that protect cells from radiation
damage—include substances containing sulfhydryl groups (-SH), such as cysteine
and cysteamine. These agents protect normal cells from radiation damage by combining with free radicals that are produced by radiation and would be toxic to normal cells. However, these compounds cause severe adverse reactions such as nausea
and vomiting.
Less toxic compounds have been developed in which the -SH group is protected
by a phosphate group. The phosphate group is hydrolyzed invivo to release the -SH
group for radioprotection. Two most effective compounds of this category are
WR-638 and WR-2721 developed at Walter Reed Army Hospital, Washington,
DC.Experimental evidence showed that these products concentrate more in normal
cells and less in tumor cells. As a result, normal cells are protected better than tumor

334
cells if these agents are administered immediately before the radiation dose is given.
WR-2721, also called amifostine, is an aminothial and protects bone marrow. Its
most common toxic effects are hypotension and somnolence. Radioprotectors are
most effective with low-LET radiations, because they cause minimal damage.
17 Radiation Biology
17.9 Apoptosis
While necrosis results from uncontrolled cell death due to cell lysis or inammatory responses, apoptosis or programmed cell death occurs in a controlled fashion
in that the cells play an important role in their own death. It is characterized by a
sequence of stereotyped events that take place in discrete phases, following stress
induced by a variety of external stimuli. Radiation is one of the stimuli that causes
stress in the cell, whereby a group of proteins called caspases are activated. These
proteins break down the key cellular components essential for normal cell function, ultimately resulting in the breakdown of the chromatin. Cells then condense
to form membrane- enclosed horseshoe-like bodies, which are phagocytosed by
nearby macrophages, leading to apoptosis. Apoptosis typically occurs in all
species.
17.10 Classification ofRadiation Damage
Cell death is a measure of extreme radiation damage. Therefore, based on the degree
of lethality induced by radiation, radiation damage can be classied into three categories: (1) lethal damage, which causes irreversible death; (2) sublethal damage
(SLD), which normally repairs in hours, and thus avoids cellular death, unless followed by another sublethal damage; and (3) potentially lethal dose (PLD), which
can potentially kill the cell but can be modied to repair under specic physicochemical conditions. All these damages are relevant in clinical radiation therapy as
to the effectiveness of treatment. Lethal damage is a denite end point in treatment,
whereas SLD and PLD have variable effects in radiation therapy.
Sublethal damage occurs in mammalian cells, when a radiation dose is given in
fractions at different time intervals rather than a single dose. There are four mechanisms, the so-called four R’s that play a role in the SLD repair (SLDR) mechanism:
repair, redistribution, regeneration, and reoxygenation. Repair involves the healing
of the radiation-induced damage in the time interval between the two fractions of
the dose. If the second dose is applied too soon after the rst application, the damage does not have enough time to repair, and the cell will die. In fractionated radiotherapy, normal tissues are spared by SLD because of its repair mechanism. In the
redistribution process, the cells are desynchronized and sensitized to show increased
damage. Following irradiation, the radiosensitive cells will die, and one would
expect the proportion of radioresistant cells and hence the surviving fraction to
increase. In fact, however, the surviving cells become sensitized and tend to die.
This result depends on the fractionated dose and the time interval between the doses.

17.11 Sources ofRadiation Exposure intheUnited States
335
Regeneration is a mechanism of response to depopulation of a cell cohort due to
radiation damage, and depends on the types of tissue and their proliferating capacity. Protracting a fractionated dose should be benecial to normal tissues and somewhat harmful to regenerating tumor cells. Reoxygenation, discussed earlier is an
effect that makes the hypoxic cells more radiosensitive in the presence of oxygen in
fractionated radiotherapy.
Sublethal damage repair depends very much on the dose rate and in which stage
of the cell cycles the cells are. At lower doses, more SLD can be repaired, and at
higher doses, the chances of SLD repair diminish. The dose-rate effect varies with
the types of tissue and species. For example, the testis of male rats is most radiosensitive, whereas the small intestine seems to be less affected by radiation. Also, SLD
repair depends on the LET of the radiations. The repair is signicant with x-rays and
γ-rays and almost nonexistent for neutrons and α-particles. SLD repair is very
important in radiation therapy as it provides maximum survival of normal cells,
while killing tumor cells.
Potentially lethal damage after a single dose of radiation can potentially kill the
cell, but it can be repaired (PLDR) under specic physicochemical conditions. For
example, the survival of the HeLa cells increased after irradiation when the cells
were treated with excess thymidine or hydroxyurea for a period of 4h postirradiation. However, opposite results were obtained by other investigators. The importance of PLDR in radiotherapy is a matter of debate.
PLDR and SLDR are found with low-LET radiations (e.g., γ-rays and x-rays giving cell survival curves with a broad shoulder), while they are absent for high LET
radiations (neutrons and α-particles).
17.11 Sources ofRadiation Exposure intheUnited States
The population at large receives radiation exposure from various sources such as
ubiquitous natural background radioactivity, medical procedures, consumer products, activities related to industrial, security, medical, and educational research, and
occupational sources. The estimates of various exposures are tabulated in Table17.2.
Annual total exposure for individuals in the US has signicantly increased from
~360 mrem (3.6 mSv) in 1980–1982 to 625 mrem (6.25 msv) in 2006. Much of the
increase is largely due to the prolic growth of medical procedures.
Ubiquitous background radiation comprises radon and thoron, cosmic rays,
invivo radionuclides, and terrestrial radiation. Radon (
exist in building materials and are prevalent in the basement of buildings. This exposure is an internal exposure due to inhalation of these gaseous products and amounts
to 212 mrem (2.12 mSv) and 16 mrem (0.16 mSv), respectively, accounting for
almost 37% of the total exposure.
Cosmic rays originate in the solar system and the exposure varies with the altitude of places on Earth. The average value is ~33 mrem (0.33 mSv) (5%) with a
range of 28 mrem (0.28 mSv) in Honolulu and 82 mrem (0.82 mSv) in Colorado
Springs.
222
Rn) and thoron (
220
Rn)

336
17 Radiation Biology
Table 17.2
for 2006
Sources
Natural sources 311 (3.11)
Radon & thoron 228 (2.28)
External, space 33 (0.33)
External, terrestrial 21 (0.21)
Internal, ingestion 29 (0.29)
Medical procedures 300 (3.0)
CT 147 (1.47)
Nuclear medicine 77 (0.77)
Interventional radiology 43 (0.43)
Conventional radiography and uoroscopy 33 (0.33)
Consumer products 13 (0.13)
Industrial, security, medical, education and
research
Occupational 0.5 (0.005)
Total ~ 625 (6.25)
a
Reprinted with permission of the National Council on Radiation Protection and Measurements,
http://NCRPPublications.org. NCRP No 160: Table1.1
Annual effective dose per individual in the U.S. population from different sources
a
Average annual effective dose in mrem
(mSv)
0.3 (0.003)
The invivo radioactivity consists of natural 40K,
232
Th, and
238
U present in food
and water, and are ingested internally by humans. This exposure amounts to 29
mrem (0.29 mSv) (4%).
The terrestrial radiation exposure arises from radionuclides such as 40K and the
decay products of thorium and uranium in soil. Annually this adds about 21 mrem
(0.21 mSv) (3%).
Air travel at a height of 39,000 ft (12 km) gives 0.5 mrem/h (5 μSv/h) resulting
in an annual dose of 1 mrem (0.01 mSv) to those who y.
Medical procedures contribute the highest exposure of all man-made radiation
sources amounting to ~300 mrem (3.0 mSv). The breakdown of these exposures is
as follows: CT (49%); nuclear medicine (26%); interventional radiology (14%), and
conventional radiography and uoroscopy (11%). Exposure from radiation therapy
is relatively small.
Exposure due to industrial, security, medical education and research activities
arise from the use of radioactivities in nuclear the fuel cycle, by the Departments of
Energy and Homeland Security, by investigators in research, and radiactive waste
disposal by medical facilities. The public is exposed to radiations from these sources
in an annual average of 0.3 mrem (0.003 mSv).
Occupational exposure is received by the workers in reactor plants, coal mines,
and other industries using radionuclides. This value is 0.5 mrem (0.005 mSv), which
is quite small, because a great deal of precaution is taken to reduce exposure at
work places.

17.13 Acute Eects ofTotal Body Irradiation
337
17.12 Stochastic andDeterministic Effects
Two categories of radiation effects on biological systems are encountered: stochastic and deterministic. Stochastic effects are the biological effects that occur randomly, the probability of which increases with increasing dose without a threshold.
Radiation-induced hereditary effects and cancer incidences are examples of stochastic effects. The assumption of no threshold is made on the belief that radiation
damage to a few cells or a single cell could theoretically induce the genetic disorder
or cancer, and the severity of the disease will be the same, if it ever occurs. It should
be noted that the basic principle of ALARA (as low as reasonably achievable) in
Nuclear Regulatory Commission (NRC) regulations is based on the assumption of
risks linearly proportional to the dose without a threshold. Much debate has occurred
regarding the assumption of the linear-nothreshold (LNT) theory (discussed below).
The deterministic or nonstochastic effects are induced by high radiation doses
and the severity of the damages, rather than their probability of occurrence, increases
with the dose. These effects have a threshold dose below which no damage is evident. Cataracts, skin erythema, sterility, and brosis are examples of deterministic
effects induced by high radiation doses.
17.13 Acute Effects ofTotal Body Irradiation
Different tissues of the body respond differently to radiation, due to varying degrees
of radiosensitivity. When an adult subject is irradiated over the entire body, various
syndromes are manifested depending on the dose applied. The effects of radiation
are characterized by the survival time of the species and various stages of acute
syndromes following the total-body irradiation. These effects are deterministic
types and have a threshold dose.
Cell survival time varies with mammal species depending on the individual
radiosensitivity. The radiosensitivity of a given species is commonly characterized
by the lethal dose, LD
The LD
for humans is 400–600 rad (400–600 cGy); for dogs, 300 rad (300 cGy);
50/60
, which is the dose that kills 50% of the species in 60 days.
50/60
and for mice, 900 rad (900 cGy).
Acute radiation syndromes appear in four stages: prodromal, latent, manifest illness, and recovery or death. Each stage is dose dependent and can last for a few
minutes to weeks. A minimum of 200–300 rad (200–300 cGy) is required for all
four stages to be seen and can cause death.
In the prodromal stage, major symptoms are nausea, vomiting, and diarrhea and
they occur in the early phase, lasting for only a short period of time depending on
the dose. A dose of 50 rad (50 cGy) can induce nausea and vomiting. In the latent
stage, biological damage slowly builds up without manifestation of any syndromes,
again lasting for hours to weeks, depending on the dose. During the manifest illness
stage, radiation syndromes appear as a result of the damage to the organs involved
after the latent period, and the subject becomes ill. In the last stage, the subject
either recovers or dies.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
